Mechanisms and clinical relevance of bacterial heteroresistance

DI Andersson, H Nicoloff, K Hjort - Nature Reviews Microbiology, 2019 - nature.com
Antibiotic heteroresistance is a phenotype in which a bacterial isolate contains
subpopulations of cells that show a substantial reduction in antibiotic susceptibility …

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

K Dheda, T Gumbo, G Maartens, KE Dooley… - The lancet Respiratory …, 2017 - thelancet.com
Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

CJ Meehan, GA Goig, TA Kohl, L Verboven… - NATURE reviews …, 2019 - nature.com
Whole genome sequencing (WGS) of Mycobacterium tuberculosis has rapidly progressed
from a research tool to a clinical application for the diagnosis and management of …

Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: updates on recent developments in the field

N Dookie, A Khan, N Padayatchi, K Naidoo - Frontiers in Microbiology, 2022 - frontiersin.org
The World Health Organization's End TB Strategy prioritizes universal access to an early
diagnosis and comprehensive drug susceptibility testing (DST) for all individuals with …

Best practices for evaluating single nucleotide variant calling methods for microbial genomics

ND Olson, SP Lund, RE Colman, JT Foster… - Frontiers in …, 2015 - frontiersin.org
Innovations in sequencing technologies have allowed biologists to make incredible
advances in understanding biological systems. As experience grows, researchers …

[HTML][HTML] Mycobacterium tuberculosis and whole-genome sequencing: how close are we to unleashing its full potential?

G Satta, M Lipman, GP Smith, C Arnold, OM Kon… - Clinical Microbiology …, 2018 - Elsevier
Background Nearly two decades after completion of the genome sequence of
Mycobacterium tuberculosis (MTB), and with the advent of next generation sequencing …

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

GR Davies, M Chaplin, M De Vos… - Cochrane Database …, 2022 - cochranelibrary.com
Background The World Health Organization (WHO) End TB Strategy stresses universal
access to drug susceptibility testing (DST). DST determines whether Mycobacterium …

Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects

D Lal, P Keim, J Delisle, B Barker… - International forum of …, 2017 - Wiley Online Library
Background The role of microbiota in sinonasal inflammation can be further understood by
targeted sampling of healthy and diseased subjects. We compared the microbiota of the …

[PDF][PDF] Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex

World Health Organization - 2022 - apps.who.int
Under the terms of this licence, you may copy, redistribute and adapt the work for non-
commercial purposes, provided the work is appropriately cited, as indicated below. In any …

Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation

RE Colman, A Mace, M Seifert, J Hetzel… - PLoS …, 2019 - journals.plos.org
Background Accurate, comprehensive, and timely detection of drug-resistant tuberculosis
(TB) is essential to inform patient treatment and enable public health surveillance. This is …